Anzeige
Meldung des Tages: 9 von 13 Treffern in den ersten 25 Metern: Wird das der Gamechanger für diese Goldaktie?

Roche Holding Aktie News

Aktie
WKN:  851311 ISIN:  CH0012032113 US-Symbol:  RHHBF Branche:  Pharmazeutika Land:  Schweiz
344,40 CHF
-2,00 CHF
-0,58%
375,18 € 09:22:40 Uhr
Depot/Watchlist
Marktkapitalisierung *
250,27 Mrd. €
Streubesitz
17,13%
KGV
25,93
Dividende
9,70 CHF
Dividendenrendite
2,89%
neu: Nachhaltigkeits-Score
48 %
Index-Zuordnung
-

Roche Holding News

12.02.25 - GlobeNewswire
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
Evrysdi is the only non-​invasive disease-​modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same ...
07.02.25 - GlobeNewswire
New England Journal of Medicine publishes new data for Roche’s Gazyva/Gazyvaro which shows superiority over standard therapy in people with active lupus nephritis
Nearly half of patients on Gazyva/Gazyvaro plus standard therapy achieved a complete renal response (CRR), with a statistically significant and clinically meaningful improvement, ...
04.02.25 - GlobeNewswire
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) With as few as two treatments per ...
31.01.25 - GlobeNewswire
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU
As seen in the DESTINY-Breast06 trial, a pproximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered HER2-ultralow. 1 ...
30.01.25 - GlobeNewswire
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2024 results with 7% sales growth; fourth quarter marks third straight quarter of 9% growth
Basel, 30 January 2025
30.01.25 - GlobeNewswire
[Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche erzielt starkes Jahresergebnis für 2024 mit Verkaufswachstum von 7%; drittes Quartal in Folge mit 9% Wachstum
Basel, 30. Januar 2025
29.01.25 - GlobeNewswire
Change to the Roche Enlarged Corporate Executive Committee
Basel, 29 January 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that  Wafaa Mamilli (1967) will join the company as Chief Digital Technology Officer (CDTO), ...

Newssuche

Videos

newspaper
27.01.26 +1,29%
Technical Trading: Pfund Short
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »